The head of the who announced a "scientific breakthrough" in the treatment of coronavirus

In the treatment COVID-19 occurred "scientific breakthrough", said the Director General of the who tedros adhanom Ghebreyesus.

He commented on the results of clinical trials in the UK steroid dexamethasone for treating coronavirus infection.

"This is the first drug that showed a decrease in the level of mortality among patients with COVID-19 who need oxygen therapy or artificial ventilation," he said Ghebreyesus, calling the scientific results "great news."

Who officials reported that the London organization provided the preliminary results of Patani. In the organization added that "eagerly" await the full analysis of information in the near future.

Held in Oxford study found that anti-inflammatory drug dexamethasone reduces the risk of death in patients COVID-19 to 35 percent is connected to the ventilator, and 20 percent among patients receiving oxygen.

During the test, the drug took the patient 2104 six milligrams daily for ten days.

Packaging medicines in Britain is only about five pounds (437 rubles. — Approx. ed.). The United Kingdom government on Tuesday approved a drug for the treatment of coronavirus. The drug has been known for over 60 years and is used as an anti-inflammatory.

The study, in particular, praised Prime Minister Boris Johnson. According to him, the results of the scientific work was "the largest currently breakthrough" in the fight against COVID-19.

According to estimates, if the opening has been done before in the country could have been saved about five thousand lives.

Opening in Oxford commented on also in Egypt, where, according to the head of the Egyptian Scientific Committee for the fight against the coronavirus Hussam Hosni, dexamethasone used to treat COVID-19 with positive results before the announcement of the registration of medicines in the UK.

"The UK has succeeded that were able through the media to replicate this medication, although Egypt used it before her," said Hosni live Sada el-Balad.

He added that the drug is used for the treatment of patients with coronavirus in the middle and severe stage. However, medication can only be used in hospitals under the supervision of doctors, said Hosni.

The Chinese authorities 31 December 2019 has informed who of an outbreak of an unknown pneumonia in Wuhan in the Central part of the country (Hubei province). Experts have established that the causative agent was a new coronavirus, infection later received the official name COVID-19. March 11, the who declared the pandemic COVID-19.

According to the organization, in the world revealed more than 7.9 million infections, over 434 thousand people died.

Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.